|
Market Cap (3-Jul) $617,674,048 (1,200th) |
Close (30-Jun) $0.130 |
Volume (30-Jun) 13,196,801 |
Shortsold (19-Jun) 70,661,833 (3.60%) (67th) |
|
52w High $0.54 |
52w Low $0.283 |
P/E - |
EPS -0.02 |
BOT released this announcement to the ASX on 29 April 2022, 8:38. The announcement is marked as price sensitive, and is 9 page(s) in length and 357.73kb in size.
You can view all announcements from BOT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BOT was 0.232% short sold according to ASIC data. It was ranked the 403rd most shorted stock on the ASX. It is now ranked as the 67th most shorted stock on the ASX with 3.604% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from BOT | |
|---|---|
| Section 708A(5)(e) Notice | 27 June 2023, 19:11 |
| Application for quotation of securities - BOT | 27 June 2023, 19:07 |
| Section 708A(5)(e) Notice | 15 June 2023, 14:07 |
| Appendix 4C - Quarterly | 29 April 2022, 8:38 |
| FDA Qualified Infectious Disease Product Status for BTX 1801 | 28 April 2022, 8:40 |
| Botanix upcoming presentation - Health Economics Conference | 22 April 2022, 8:49 |
| Notification regarding unquoted securities - BOT | 14 April 2022, 18:50 |
You must be logged in to post a reply.
Botanix Pharmaceuticals 